1SUGIMURA T,KATO H,INOUE O,et al.Intravascular ultrasound of coronary arteries in children:assessment of the wall morphology and the lumen after kawasaki disease[J].Circulation,1994,89:258-265. 被引量：1
2OU C Y,TSENG Y F,LEE C L,et al.Significant relationship between serum high-sensitivity C-reactive protein,high-density lipoprotein cholesterol levels and chidren with Kawasaki disease and coronary artery lesions[J].J Formos Med Assoc,2009,108:719-724. 被引量：1
3MITANI Y,SAWADA H,HAYAKAWA H.Elevated levels of high-sensitivity C-reactive protein and serum amyloid-A late after Kawasaki disease:association between inflammation and late coronary sequelae in Kawasaki disease[J].Circulation,2005,111:38-43. 被引量：1
4KATE H,LNOUE O,KAWASAKI T,et al.Adult coronary artery disease probably due to childhood Kawasaki disease[J].Lanect,1992,340:1127-1129. 被引量：1
5Committee.Guidelines for diagnosis and management of cardiovascular sequelae in Kawasaki disease[J].Pediatr Int,2005,47:711-732. 被引量：1
6CHEUNG Y F,FUO K,WOO C W,et al.Oxidative stress in children late after Kawasaki disease relationship with carotid atheroscleross and stiffness[J].BMC Pediatr,2008,8:20-23. 被引量：1
7MCMAHON M A,WYNNE B,MURPHY G M,et al.Recurrence of Kawasaki disease in an adult patient with cholecystitis[J].Ir Med J,2007,100:400-401. 被引量：1
8IEMURA M,ISHII M,SUGIMURA T,et al.Long term consequences of regressed coronary aneurysms after Kawasaki disease:vascular wall morphology and function[J].Heart,2000,83:307-311. 被引量：1
9CUNHA B A,PHEREZ F M,ALEXIADIS V,et al.Adult Kawasaki's disease with myocarditis,splenomegaly,and highly elevated serum ferritin levels[J].Heart Lung,2010,39:164-172. 被引量：1
10NEWBURGER J W,TAKAHASHI M,GERBER M A,et al.Diagnosis,treatment,and long-term management of Kawasaki disease:a statement for health professionals from the Committee on Rheumatic Fever,Endocarditis and Kawasaki Disease,Council on Cardiovascular Disease in the Young,American Heart Association[J].Circulation,2004,110:2747-2771. 被引量：1
5ROWLEY A H, SHULMAN S T. Pathogenesis and management of Kawasaki disease[J]. Expert Rev Anti Infect Ther, 2010,8 ~ 197- 203. 被引量：1
6CASTAMAN G, GHIOTTO R, DUGA S, et al. A novel fibrinogen gamma chain mutation (gamma 239 Gin- His) is the cause of dysfibrinogenemia Vi- cenza[J]. J Thromb Haemost, 2005,3 : 600- 601. 被引量：1
9Tracke CE, Burgner D, Kuipers IM, et al. Management of a- cute and refractory Kawasaki disease [ J ] . Expert Rev Anti Infect Ther, 2012, 10 (10) : 1203 -1215. 被引量：1
10Kumar A, Sivakanesan R, Gunasekera S. Ischemia modified al- bumin:a potent marker in acute myocardial infarction in normo- lipidaemic[ J]. Pak J Med Sci ,2008,24:364 - 367. 被引量：1
